Chronic low-grade inflammation is a common pathological feature of both: metabolic disturbances in patients with DM induce the release of peripheral inflammatory factors, and these inflammatory factors pass through the compromised BBB into the central nervous system (CNS), activating microglia and astrocytes and triggering a neuroinflammatory cascade response, which in turn promotes A deposition in AD and tau protein hyperphosphorylation (Sebastian Monasor et al., 2020
If you experience hypoglycemia (low blood sugar levels), stop taking other glucose-lowering medications such as metformin and insulin glargine after consulting with your healthcare professional
Tirzepatide (Mounjaro): Also once weekly, despite its dual action on GLP-1 and GIP receptors
Pressure Tactics Typical strategies are time-sensitive discounts, today only upgrades and pressure to sign financing right now
Related: Stopping GLP-1 Drugs Triggers Weight Regain 4x Faster Than Ending Exercise "It's very common for pharmaceutical companies to collect genetic data on their participants," says Gloyn
Adverse effects Besides nausea which was more frequent in the GLP-1RA group (40 vs 4%), there was no difference in the occurrence of adverse effects
